Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001836891-21-000001
Filing Date
2021-03-02
Accepted
2021-03-02 16:16:16
Documents
1
Effectiveness Date
2021-03-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10074
  Complete submission text file 0001836891-21-000001.txt   11103
Mailing Address 321 DEDALERA DR. PORTOLA VALLEY CA 94028
Business Address 321 DEDALERA DR. PORTOLA VALLEY CA 94028 650-575-1702
Angarus Therapeutics, Inc. (Filer) CIK: 0001836891 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-384604 | Film No.: 21703793